Your browser doesn't support javascript.
loading
Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans.
Piel, Isabel; Engelen, Anna; Lang, Dieter; Schulz, Simone I; Gerisch, Michael; Brase, Christine; Janssen, Wiebke; Fiebig, Lukas; Heitmeier, Stefan; Kanefendt, Friederike.
Afiliación
  • Piel I; Drug Metabolism and Pharmacokinetics, Bayer AG, Wuppertal, Germany.
  • Engelen A; Drug Metabolism and Pharmacokinetics, Bayer AG, Wuppertal, Germany.
  • Lang D; Drug Metabolism and Pharmacokinetics, Bayer AG, Wuppertal, Germany.
  • Schulz SI; Drug Metabolism and Pharmacokinetics, Bayer AG, Wuppertal, Germany.
  • Gerisch M; Drug Metabolism and Pharmacokinetics, Bayer AG, Wuppertal, Germany.
  • Brase C; Clinical Pharmacology, Bayer AG, 42096, Wuppertal, Germany.
  • Janssen W; Drug Metabolism and Pharmacokinetics, Bayer AG, Wuppertal, Germany.
  • Fiebig L; Drug Metabolism and Pharmacokinetics, Bayer AG, Wuppertal, Germany.
  • Heitmeier S; Preclinical Pharmacology, Bayer AG, Wuppertal, Germany.
  • Kanefendt F; Clinical Pharmacology, Bayer AG, 42096, Wuppertal, Germany. friederike.kanefendt@bayer.com.
Eur J Drug Metab Pharmacokinet ; 48(4): 411-425, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37365440
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factor XIa / Anticoagulantes Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factor XIa / Anticoagulantes Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article